BACKGROUND: Rural US women experience disparities in breast cancer screening and outcomes. In 2006, a national rural health insurance provider, the National Rural Electric Cooperative Association (NRECA), eliminated out-of-pocket costs for screening mammography. METHODS: This study evaluated the elimination of cost sharing as a natural experiment: it compared trends in screening before and after the policy change. NRECA insurance claims data were used to identify all women aged 40 to 64 years who were eligible for breast cancer screening, and mammography utilization from 1998 through 2011 was evaluated. Repeated measures regression models were used to evaluate changes in utilization over time and the association between screening and sociodemographic factors. RESULTS: The analysis was based on 45,738 women enrolled in the NRECA membership database for an average of 6.1 years and included 279,940 person-years of enrollment. Between 1998 and 2011, the annual screening rate increased from 35% to a peak of 50% among women aged 40 to 49 years and from 49% to 58% among women aged 50 to 64 years. The biennial screening rate increased from 56% to 66% for women aged 40 to 49 years and from 68% to 73% for women aged 50 to 64 years. Screening rates increased significantly (P < .0001) after the elimination of cost sharing and then declined slightly after changes to government screening guidelines in 2009. Younger women experienced greater increases in both annual screening (6.2%) and biennial screening (5.6%) after the elimination of cost sharing in comparison with older women (3.0% and 2.6%, respectively). In a multivariate analysis, rural residence, lower population income, and lower population education were associated with modestly lower screening. CONCLUSIONS: In a national sample of predominantly rural working-age women, the elimination of cost sharing correlated with increased breast cancer screening. Cancer 2017;123:2506-15.
INTRODUCTION
Breast cancer is diagnosed in more than 200,000 US women each year and leads to death for more than 40,000 US women annually. 1 The early detection of breast cancer through screening mammography leads to an earlier stage at diagnosis, improved surgical options, and improved survival. 2, 3 In rural areas of the United States, eligible women are less likely to undergo mammographic screening for breast cancer. [4] [5] [6] Rural women also experience disparities in the breast cancer stage at diagnosis, and this correlates with inferior outcomes. 7, 8 One potential factor contributing to these disparities is the cost of screening. Historically, rates of insurance coverage have been lower in the rural United States than nonrural areas. 9 In addition, even with insurance coverage, cost sharing represents a financial barrier to health care. 10 For women in rural areas who face geographic barriers to access, cost sharing may further contribute to lower rates of breast cancer screening.
In 2008, Trivedi et al 10 reported that among Medicare beneficiaries, even modest increases in cost sharing for mammography of $10 or more were associated with approximately 10% lower rates of biennial screening mammography. The impact of cost sharing among women under the age of 65 years is unknown.
The 2010 Affordable Care Act was intended to expand access to health insurance and improve population health through mandated coverage of appropriate preventative health care. All insurance plans established after August 1, 2012 are required to provide coverage for screening mammography without copayment, coinsurance, or deductibles. The impact of this policy change on breast cancer screening has not yet been established. However, this federal policy echoed reforms that were already occurring in many insurance plans across the United States in an effort to incentivize high-value preventive health care.
One such plan was the National Rural Electric Cooperative Association (NRECA), which provides health insurance to rural electrical line workers and their families. The NRECA insures more than 100,000 health plan members in predominantly rural areas across the United States. On January 1, 2006, the NRECA introduced an all expenses-paid "well-women" primary care visit and eliminated copayment, coinsurance, and deductible fees for screening mammography for all women 40 years old or older. This policy change serves as a natural experiment and provides an opportunity to evaluate changes in screening utilization before and after the elimination of cost sharing in the same population.
The evaluation of mammography screening in this population also provided us a rare opportunity to examine other potential correlates of breast cancer screening and disparities in a national sample of rural women between the ages of 40 and 64 years. This includes the potential impact of screening guideline changes issued by the US Preventive Services Task Force (USPSTF) in November 2009.
MATERIALS AND METHODS

Data Sources and Study Population
We obtained de-identified health care claims data for all women aged 40 to 64 years in the NRECA health plan membership database between 1998 and 2011. All years with complete administrative claims and enrollment data were included. For each year, all women eligible for screening mammograms were identified in the health plan database. Eligibility was defined as female sex and an of age 40 to 64 years within that index year without a prior diagnosis of breast cancer or ductal carcinoma in situ. We excluded women with prior breast cancer or ductal carcinoma in situ on the basis of International Classification of Diseases, Ninth Revision codes 174.0 to 174.9, 233.0, and V10.3 before the index year. This study was reviewed and approved by the local institutional review board.
Outcomes
Our primary outcome of interest was the utilization of screening mammography.
We identified potential screening mammograms on the basis of claims with Current Procedural Terminology codes 77051, 77052, 77057, 76082, 76083, 76092, and S8075. We defined annual screening mammography utilization for a given year as the number of patients with a screening mammography claim divided by the number of eligible women for that year. To evaluate biennial mammographic screening, we constructed nonoverlapping 2-year intervals (eg, 1999-2000 and 2001-2002) . We defined biennial mammography utilization as the number of women with a screening mammography claim within a 2-year interval divided by the number of eligible women for that interval.
Analysis
To validate the elimination of cost sharing and to assess the magnitude of the financial impact on health plan participants, we evaluated the reported out-of-pocket patient expenses for screening mammography and examined the median, mean, and upper quartile of expenses for each index year. To evaluate the impact of the elimination of coinsurance for screening mammography in 2006, we analyzed changes in annual and biennial mammography trends before and after the policy change. We used repeated measures regression models to evaluate changes in utilization over time and to assess how screening mammography rates varied on the basis of age (reported in the NRECA database) and rural residence, income, and education (based on the patient's zip code).
Specifically, we fit a generalized estimating equation model with a binary response of the screening status in a given year (or a given 2-year period for analyses of biennial screening). The mean response was modeled as a logistic regression model under the assumption that the repeated binary responses for individual women were equally correlated; this suggested an exchangeable correlation structure. In these models, the temporal changes in screening rates were examined in 3 time periods (1998-2005, 2006-2008, and 2009-2011) by the inclusion of indicator variables corresponding to the time period for each observation. Grouping years in this way allowed us to examine how screening rates varied, in general, before the elimination of coinsurance (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , in the years immediately following the elimination of coinsurance (2006) (2007) (2008) , and in the period following a change in national screening guidelines (2009-2011) while we adjusted for other variables.
The rural or nonrural status was determined with the zip code approximation for rural-urban commuting area codes developed by the US Department of Agriculture on the basis of 2010 US Census data. Because patient-level information on income was not available, we assessed the effect of income with a surrogate variable defined as the percentage of households in a patient's zip code with an income below the poverty level in the past year. Similarly, the effect of education was evaluated via a surrogate variable defined as the percentage of adults in a patient's zip code with a college education. Education and income data were based on the 2010 American Community Survey produced by the US Census. Interaction terms were added to the multivariate model to determine whether the pattern of change in screening rates over time differed according to age, rural residence, income, or education. Analyses were performed with SAS 9.4, and 2-sided statistical tests were used throughout.
RESULTS
This analysis is based on eligible women aged 40 to 64 years who were identified in the NRECA membership database between 1998 and 2011. During this period, the mean number of eligible women in a given year was 19,996; this declined from a peak of 22,085 in 1998 to a low of 18,988 in 2011. Our analysis is based on data from 45,738 women enrolled for an average of 6.1 years; it included 279,940 person-years of enrollment. Population characteristics for eligible women enrolled during this period are presented in Table 1 .
To verify that coinsurance had been eliminated in accordance with NRECA policy in 2006 and to determine the magnitude of the financial change, we evaluated total out-of-pocket patient expenses reported by the NRECA, including copayments, coinsurance, and deductibles associated with screening mammography claims before and after the policy change. The mean out-of-pocket payment for mammography screening in 2005 was $14, the median payment was $0, and the upper quartile payment was $20. After 2006, the mean out-of-pocket payment was $2, the median payment was $0, and the upper quartile payment was $0. In the bivariate analysis, an age greater than 50 years was associated with increased annual screening (odds ratio [OR], 1.49; 95% confidence interval [CI], 1.46-1.52; P < .0001), and there was an increase in annual screening for women living in areas with a higher level of college education (OR for a 10% increase in the percentage with a college education, 1.04; 95% CI, 1.03-1.05; P < .0001). Modestly lower rates of annual screening were associated with rural residence (OR, 0.92; 95% CI, 0.90-0.95; P < .0001) and living in a zip code with lower household incomes (OR for a 10% increase in the percentage below the poverty level, 0.92; 95% CI, 0.91-0.94; P < .0001). As shown in Table 2 , these factors were also associated with annual screening in the multivariate analysis. In the bivariate analysis, the findings were similar to the associations seen for annual screening described previously. An age 50 years or older was associated with increased biennial screening (OR, 1.40; 95% CI, 1.37-1.44; P < .0001), as was living in an area with a higher level of college education (OR, 1.05; 95% CI, 1.04-1.07; P < .0001). Lower rates of at least biennial screening were associated with rural residence (OR, 0.92; 95% CI, 0.88-0.95; P < .0001) and living in an area with a lower household income (OR, 0.9; 95% CI, 0.88-0.92; P < .0001). With the exception of rural residence, these associations persisted in the multivariate analysis (Table 3) .
Impact of the Elimination of Cost Sharing on Screening Mammography
As demonstrated in Figure 1 , screening rates were increasing over time even before the NRECA policy change to eliminate out-of-pocket expenses in 2006. To evaluate the potential impact of eliminating cost sharing, we examined mammography rates during 3 distinct time periods representing the period before the elimination of cost sharing (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , the period following the policy change (2006) (2007) (2008) , and the period following a change in national screening guidelines (2009-2011). The annual screening mammography rates for these periods were 47.6%, 52.6%, and 53.0%, respectively. There was an absolute increase of 5.0% (P < .0001) in the annual screening rate after the elimination of cost sharing for mammography in 2006.
In the bivariate analysis, there was a significant increase in annual mammography utilization for both time periods after the elimination of cost sharing in comparison with the earlier time period (P < .0001 for both). Looking at annual screening across these 3 time periods among younger women, we found that the screening rate rose from 41.4% in 1998-2005 to 47.6% in the years immediately after the policy change in 2006-2008 and then remained stable at 48.0% in 2009-2011. This suggests a greater than 6% absolute increase in annual screening after the NRECA policy change.
Among older women aged 50 to 64 years, trends for annual screening were similar to those observed for younger women, but the overall rates were higher. In the period 1998-2005, the annual screening rate was 53.5%; in 2006-2008, the rate was 56.5%; and in 2009-2011, it remained roughly steady at 56.6%. In the multivariate analysis, the interaction of age and time period was statistically significant, and this indicated that younger women experienced a greater increase in screening than women who were 50 years or older after the elimination of cost sharing.
We also examined changes over time for biennial screening with respect to the NRECA policy change. The intervals reflect the evaluation of 2-year nonoverlapping periods to capture biennial screening. The rates of all Although we cannot directly assess the impact of cost sharing on individual screening decisions, if the time periods before and after the policy change are taken as surrogates for the elimination of cost sharing, the impact was greater among younger women, with an OR for annual screening of 1.33 (95% CI, 1.292-1.376; P < .0001) for 2009-2011 versus 1998-2005, whereas the OR was 1.136 (95% CI, 1.17-1.167; P < .0001) among women aged 50 to 64 years. This was also true for the impact of the elimination of cost sharing on biennial screening rates among younger women versus older women in this population. Annual screening rates were also lower for women living in rural areas (OR, 0.96; 95% CI, 0.93-0.99; P 5 .01) and in areas with generally lower household incomes (OR for a 10% increase in the percentage below the poverty level, 0.95; 95% CI, 0.93-0.97; P < .0001), and they were slightly higher for women living in areas with higher education levels (OR for a 10% increase in the percentage with a college education, 1.02; 95% CI, 1.01-1.03) according to the multivariate analysis (Table 2) . Similarly, biennial screening rates were lower for women living in areas with lower household incomes (OR, 0.92; 95% CI, 0.90-0.95; P < .0001) and higher for women living in areas with a greater extent of college education (OR, 1.04; 95% CI, 1.02-1.05; P < .0001), but they were not associated with rural residence in the multivariate model (P 5 .12; Table 3 ). 
DISCUSSION
Rates of both annual and biennial mammography screening for breast cancer increased modestly after an insurance policy change to eliminate cost sharing in this population of insured predominantly rural US women. Although it is difficult to determine causality for a temporal trend in health care utilization, it is possible that the elimination of even small financial barriers to patients (ie, $14 on average before the policy change) may be associated with increased screening. This is consistent with data from other health care contexts, such as copayments for medication, where studies have shown that small financial barriers can affect health care utilization. 11, 12 Cost sharing is increasingly implemented as a tool to expose patients to health care costs and thus help control the overall costs of care, but it has the potential to curtail high-value and low-value aspects of health care. 13 Currently, the Affordable Care Act mandates coverage of breast cancer screening, but debate over health insurance reform and components of mandated coverage continues in the United States. These debates should be informed by the impact that both a lack of insurance and cost shifting to patients can have on high-value components of health care. Our study suggests that the removal of even small financial barriers to breast cancer screening may result in a 3% to 6% increase in screening, with the greatest impact among younger women.
From a policy perspective, even these modest increases in screening could yield important public health and economic impacts. In concrete terms, we found that the elimination of cost sharing for screening mammograms in the NRECA population of approximately 20,000 screening eligible women per year was associated with up to 1200 more women undergoing annual screening and with 1000 more women undergoing at least biennial screening. We did not evaluate outcomes, and there is considerable debate about the relative benefits of screening mammography, particularly among women aged 40 to 49 years. The impact of increased screening depends on the assumptions regarding the benefits of early detection. However, this increase in screening approaches the number needed to be screened to prevent 1 breast cancer death annually according to the USPSTF (depending on the age of the population).
14 In addition, screening results in early diagnosis and may reduce the morbidity and cost of subsequent treatment. A comparison of women with screening-detected and non-screening-detected cancers suggested a 26% lower risk of lymph node-positive disease and a 28% lower likelihood of receiving chemotherapy. 2, 15 Among 1200 women undergoing annual screening, it is expected that 24 to 40 will be diagnosed with breast cancer according to the age of the population. Within this group, early detection could result in 6 to 10 patients avoiding chemotherapy. In strict financial terms, eliminating mean cost sharing of $14 in the NRECA population for 10,000 women screened at a total cost of $140,000 annually appears to be sound economic policy. A recent study estimated breast cancer chemotherapy costs alone of more than $80,000 per patient. 16 Furthermore, the costs of breast cancer care in the last year of life exceed $90,000. 17 Thus, in addition to reducing morbidity and mortality (the major goal of screening and early detection), this policy may have saved NRECA more than $400,000 per year. If this is extrapolated to all of the approximately 6.8 million rural US women between the ages of 40 and 64 years, more than 300 lives might be saved each year, more than 2000 women might avoid chemotherapy, and we could save more than $100 million in annual health care costs. These rough estimates, which should be refined in a formal cost-effectiveness analysis, are based on modest increases in screening within an insured population with relatively small cost-sharing burdens at the baseline. The impact of a continued national policy of full coverage for screening mammography in comparison with the elimination of such coverage is expected to be greater on the basis of screening patterns among uninsured rural women. 4 Our study results are consistent with data for older women from Trivedi et al, 10 who found that the elimination of cost sharing ranging from $12 to $35 (median, $20) in a national sample of Medicare enrollees was associated with an increase in the rate of breast cancer screening from 69.2% to 77.5%. Jena et al 18 found that the elimination of a $20 copayment among more than 50,000 continuously enrolled Medicare Advantage members was associated with a 1.4% higher rate of breast cancer screening over time. Our data supplement this literature by demonstrating the potential impact of the elimination of cost sharing on screening patterns in an insured working-age population.
There is perennial controversy over the role of screening mammography and the extent to which breast cancer screening does or does not represent high-value health care. Expert guidelines not only varied but also changed during the period evaluated in this analysis (Table 4) . Nevertheless, although guidelines and the science behind them will continue to evolve, it is important to understand factors that affect cancer screening utilization. Exploring breast cancer screening among insured US women with the novel NRECA administrative claims data, we found that overall, rates were low, with well under half of eligible women aged 40 to 49 years and just more than half of women aged 50 to 64 years receiving annual screening. Even for biennial screening, more than one-third of eligible women aged 40 to 49 years and more than 25% of women who were aged 50 years or older were unscreened.
These data are also consistent with other studies of breast cancer screening in rural populations. Among women receiving health care through a federally qualified health center in rural North Carolina, Paskett et al 4 found that only 58% reported screening mammography within the past 3 years, and 24% had never undergone screening mammography. One-third of these women lacked health insurance. In a study of women attending a food pantry in rural Pennsylvania, Bencivenga et al 5 reported annual screening mammography for only 57.9% of women in rural Pennsylvania despite high rates (>88%) of health insurance in this population. These studies used survey data to assess breast cancer screening, which may overestimate screening in comparison with the claims data used in our study. Although our data were similar, our population is not representative of all rural US women. In the NRECA population, approximately two-thirds of women resided in a rural zip code, and all had insurance coverage. However, screening rates among these women were lower than rates among those living in urban zip codes. Our findings were similar to those by Jackson et al, 6 who found 4% lower rates of screening mammography in rural areas versus urban areas of California. Rural women should be considered an appropriate target population for interventions to improve screening rates overall and to reduce disparities in screening.
Interestingly, we found that rural residence was associated with lower rates of annual screening but not biennial screening in a multivariate analysis. It is unclear whether differences in annual screening are due to distance as a barrier to screening, practice patterns among physicians ordering screening, patient preferences, or other factors. Future research should include efforts to understand the specific causes of differences in screening, which may inform interventions.
In addition to rural residence, modest disparities in screening in the NRECA population were identified on the basis of regional sociodemographic education and household income levels, as reported in other studies. 10, 19 In our multivariate model, women were 8% less likely to undergo biennial screening for each 10% increase in the poverty level in their zip code. Women in this population were 4% more likely to have biennial screening for each 10% increase in the proportion of people with college education in their zip code. Geographic factors were not as important predictors of screening as age or time period when we compared screening before and after the NRECA policy change.
It is important to note that although screening rates increased after the elimination of cost sharing, a claims analysis cannot definitively demonstrate that the elimination of financial barriers caused the increase. Screening rates in this population were increasing slightly even before the policy change in 2006. This differs from national screening trends observed during this period. Using data from the Medical Expenditure Panel Survey, Miranda et al 20 found that rates of biennial screening among women aged 40 to 74 years increased slightly from 69% in 1998 to 73% in 2002 but then declined slightly over the next 5 years to 70% in 2007, with a flat overall trend. Data from the National Health Interview Survey found that the rates of women reporting at least biennial breast cancer screening were rising in the United States until In contrast, we observed a larger increase in screening rates after the 2006 policy change, and the increase was most pronounced among younger women aged 40 to 49 years. In March 1997, before the period evaluated in our study, the American Cancer Society changed screening recommendations for women aged 40 to 49 years to recommend annual screening (previously annual or biennial screening), and the National Cancer Institute first recommended breast cancer screening for this age group. It is unclear whether these guidelines affected screening in the NRECA population because we did not have data available before 1998. An evaluation of patient out-of-pocket expenses before the policy change revealed that many patients already faced low expenses. For the 5 years before the 2006 policy change, the mean out-of-pocket costs varied from $14 to $16, and the upper quartile of patients paid $20 to $25. Expenses included both coinsurance and deductibles. This limits the potential for this study to illuminate the impact that higher direct costs could have on screening or the impact of a complete loss of insurance coverage. It is also impossible to know the extent to which any impact of the NRECA policy change was psychological (ie, in response to a now free medical service) or resulted from a direct economic consideration of the difference in the cost for screening. In behavioral health economics, experiments have demonstrated that making an item free (vs merely less expensive) disproportionately increases purchasing or utilization in comparison with the actual change in cost. 22 It is also worth noting that we detected peak rates of screening in 2009, which then began to decline among both younger and older women. In 2009, the USPSTF revised its guidelines for breast cancer screening and changed the recommendation for women aged 40 to 49 years from screening every 1 to 2 years to a recommendation against routine screening starting at the age of 40 years. Our data show a modest decrease in screening after the changes in expert guidelines. Although annual screening rates were not significantly different between the 2006-2008 and 2009-2011 time periods in our multivariate analysis, biennial screening rates decreased significantly between these time periods for both younger women (7% decrease; P 5 .004) and older women (6% decrease; P 5 .002). These findings are inconsistent with several studies finding no change in the reported use of mammography screening after the 2009 guideline change. 23, 24 Interestingly, both studies that found no difference in screening after guidelines changes were based on selfreported surveys, not claims data. A third study looked at claims for breast cancer screening among women aged 40 to 64 years who were covered by commercial health insurance, and it found that there was a transient decline in screening among women aged 40 to 49 years after the 2009 guidelines, but there was little long-term impact. 25 In contrast, our data suggest lower screening rates among both younger women, the target of the new guidelines, and older women, for whom screening is still recommended.
In considering the totality of the data, we note that in the claims analysis by Wang et al, 25 screening was declining among younger and older women even in the years before the new 2009 guideline, and they continued to decline from 2009 to 2011, albeit at a slower rate. In our data, the trend after the elimination of cost sharing was increased screening, which then declined with the revised USPSTF guidelines. The new guidelines were released in November 2009. In our analysis, we include all data from 2009 in the postguideline period, and this may have diminished our ability to detect a difference between the periods before and after the guidelines changed. Despite excluding the first 10 months of 2009 before the new guidelines from the period following the elimination of cost sharing (2006-2008), we still detected a significant difference in the multivariate analysis between the periods before and after the policy change. The absolute magnitude of the impact of the elimination of copayments on screening rates was determined by an evaluation of the yearly data. It is also unclear from our data whether changes in screening guidelines had an impact beyond their intended target population or whether other factors contributed to lower screening rates among both younger and older women after 2009. Given the uncertainty over the impact of the period following the USPSTF guideline change and the unexpected increase in screening detected in the early years of this study, we conducted several post hoc analyses of the impact of the elimination of cost sharing. We compared screening in 2000-2005 and 2006-2011 and in 1998-2005 and 2006 -2011, and we repeated the regression models with the revised time periods. The results were similar, with significant increases in screening over time and a greater absolute increase for younger women versus older women for both annual and biennial screening. Absolute differences varied by 1% or less in comparison with the results for the timeframes reported above.
There are several additional limitations to this study. By evaluating claims data, we were unable to determine whether a screening mammogram was ordered and the patient decided not to get the test or a mammogram was never ordered. Furthermore, the claims used in this study were collected for administrative purposes, not research. We used validated best-practice methods to identify screening mammography, but it is possible that diagnostic mammograms performed to evaluate a symptom or physical finding were misclassified as screening studies. This would overestimate the rate of screening in the population. We also did not have direct data on race/ethnicity, education, or household income and used populationlevel zip code correlates for these variables.
We dichotomized rural status with rural-urban commuting area codes, but rural status can be defined in different ways, and the percentage of the population defined as rural and the impact of distance and access to health care may vary with the definition selected. 26 There is ongoing debate in the United States about how to expand access to high-quality care while also controlling overall costs of care. Breast cancer screening with mammography is an established method to detect breast cancer early, expand treatment options for patients, and reduce mortality from breast cancer, although the optimal age to initiate routine screening remains controversial. This study demonstrates that even among insured women, there are opportunities to improve screening rates, particularly in rural regions of the United States and particularly in geographic areas with a lower socioeconomic status. Furthermore, even with health insurance, cost sharing of $15 to $20 may reduce breast cancer screening rates, and this supports the mandate for full coverage of cancer screening and other evidence-based preventive services within the Affordable Care Act. This study demonstrates the potential of the elimination of even relatively small financial barriers to affect the utilization of preventative health care service, which may reduce morbidity and mortality and yield overall cost savings.
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